collection
MENU ▼
Read by QxMD icon Read
search

SGLT-2 Diabetes Care 2015

shared collection
5 papers 0 to 25 followers
https://www.readbyqxmd.com/read/26078479/euglycemic-diabetic-ketoacidosis-a-potential-complication-of-treatment-with-sodium-glucose-cotransporter-2-inhibition
#1
Anne L Peters, Elizabeth O Buschur, John B Buse, Pejman Cohan, Jamie C Diner, Irl B Hirsch
OBJECTIVE: Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ketoacidosis (euDKA) in hopes that it will enhance recognition of this potentially life-threatening complication. RESEARCH DESIGN AND METHODS: Cases identified incidentally are described. RESULTS: We identified 13 episodes of SGLT-2 inhibitor-associated euDKA or ketosis in nine individuals, seven with type 1 diabetes and two with type 2 diabetes, from various practices across the U...
September 2015: Diabetes Care
https://www.readbyqxmd.com/read/26125647/sodium-glucose-cotransport
#2
REVIEW
Søren Brandt Poulsen, Robert A Fenton, Timo Rieg
PURPOSE OF REVIEW: Sodium-glucose cotransporters (SGLTs) are important mediators of glucose uptake across apical cell membranes. SGLT1 mediates almost all sodium-dependent glucose uptake in the small intestine, while in the kidney SGLT2, and to a lesser extent SGLT1, account for more than 90% and nearly 3%, respectively, of glucose reabsorption from the glomerular ultrafiltrate. Although the recent availability of SGLT2 inhibitors for the treatment of diabetes mellitus has increased the number of clinical studies, this review has a focus on mechanisms contributing to the cellular regulation of SGLTs...
September 2015: Current Opinion in Nephrology and Hypertension
https://www.readbyqxmd.com/read/26125313/the-use-of-sglt-2-inhibitors-in-type-2-diabetes-and-heart-failure
#3
REVIEW
Kayla Riggs, Hiba Ali, Heinrich Taegtmeyer, Absalon D Gutierrez
The concurrent management of type 2 diabetes mellitus (T2DM) and chronic congestive heart failure presents several therapeutic challenges. Of concern is that insulin and insulin-sensitizing medications detrimentally "flood" the heart with energy-providing substrates, including fats and glucose. In this population, treatment of T2DM should focus on the reduction of increased substrate supply. Sodium glucose cotransporter-2 (SGLT-2) inhibitors, a new class of antidiabetic medication, operate via this principle by blocking the reabsorption of glucose in the kidney and subsequently releasing glucose through the urine...
September 2015: Metabolic Syndrome and related Disorders
https://www.readbyqxmd.com/read/25715413/where-does-combination-therapy-with-an-sglt2-inhibitor-plus-a-dpp-4-inhibitor-fit-in-the-management-of-type-2-diabetes
#4
COMMENT
Muhammad Abdul-Ghani
No abstract text is available yet for this article.
March 2015: Diabetes Care
https://www.readbyqxmd.com/read/25715412/sglt2-inhibitors-the-latest-new-kids-on-the-block
#5
EDITORIAL
William T Cefalu, Matthew C Riddle
No abstract text is available yet for this article.
March 2015: Diabetes Care
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"